Konrad Zielinski, founder of the startup Uhura, developed a non-invasive device called Whitney to assist laryngectomees. Zielinski, who lost his voice to cancer as a student, holds a PhD in bionic systems. The device aims to provide users with the ability to speak with emotion, laugh, and sing, avoiding the robotic sound of traditional handheld speaking tools.
Currently, Uhura markets its products as wellness devices. The basic option costs $500, while the Whitney model is priced at $1,500. Users are currently paying out of pocket, but the company is seeking Class I medical device classification in Europe and the U.S. to enable insurance reimbursement.
The startup plans to introduce higher-pitched voice options for women and personalization features to ensure unique vocal profiles. Zielinski estimates the current market for laryngectomy devices at approximately $2 billion, with potential for growth if the company expands to address other speech disorders.
Uhura faces competition from companies such as Atos Medical and Laronix. Zielinski intends to showcase the capabilities of the Whitney device at TechCrunch Disrupt and SF Tech Week in October, where he plans to demonstrate the technology by singing on stage.
